Finally, eight targets were screened through conjoint analysis and experimental verification showed that six of them including FASN, AKT1, CASP3, F2, PTGS2 and PRKCA, could be modulated by CRP in NAFLD mice. This evidence concerns the gene PTGS2 and metabolic dysfunction-associated steatotic liver disease.